Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antitumor activity of TRAIL-R1 MAb demonstrated in vitro and in vivo

Nov. 12, 2002

New antitumor hydroxamates prepared and tested at Ono

Nov. 12, 2002

Immunomedics' unlabeled CEA antibody inhibits tumor growth and enhances dacarbazine therapy

Nov. 12, 2002

Cyclis licenses broad technology to expand ACT platform

Nov. 12, 2002

Genzyme initiates kidney cancer clinical trial with innovative vaccine

Nov. 11, 2002

Genta and Aventis initiate two clinical trials with Genasense

Nov. 11, 2002

Phase IIa results show early signs of clinical activity for GCS-100 in pancreatic cancer

Nov. 11, 2002

Icos researchers identify novel inhibitors of CHK1 kinase for use as chemosensitizers

Nov. 11, 2002

December date set for advisory committee review of Bexxar

Nov. 8, 2002

Erbitux clinical development program update

Nov. 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...